Roche Navigation Menu
Roche logo
  • Search
RocheOnline
  • Up
  • Roche
  • Search
  • Close search

						
							

Searching

    • Roche
    • Medical Inquiries
      Medical Inquiries Overview
    • Roche
    • Medical Inquiries
    Close

    1 - of results for ""

    No results

    Patient Support Program

    Patient Support Program

    Roche Cares is a patient support program aimed at supporting your patient through their disease journey by enabling them to access their treatment.


    Available Patient Support Program Number of patients Eligible Patients Required Documents
    What will the patient go through? How can we support you? Frequently Asked Questions Medical Inquiries
    Available Patient Support Programs

    Available Patient Support Programs

    Enabling access to treatment

     

    Groundbreaking advances in healthcare are only meaningful when they reach the people who need them, and this is why we are committed to supporting our patients through their disease journey by offering them patient support programs tailored to their needs.

     

     

     

     

     

    Oncology programs

    Treatment supported by
    Roche Cares Program
    Patient’s Reimbursement Body Financial Services

    Perjeta®

    NSSF (in-hospital)

    • Co-payment (5%)
    • Burden alleviation
      support (Herceptin)

    Kadcyla®

    NSSF (in-hospital)

    • Co-payment (5%)

    Herceptin® SC

    NSSF (Retail Pharmacy)

    • Burden alleviation Support
    • Payment Facilitation Support
    • Flexcare Support for Herceptin® SC
      in hospital administration*

      *If applicable (This support does not include any
      additional in-hospital stay, any complications
      and disease management cost for Herceptin® SC
      patients)

    Alecensa®

    NSSF (Retail Pharmacy)

    • Co-payment (5%)
    • Payment Facilitation Support

    Tecentriq®

    NSSF (in-hospital)

    • Co-payment (5%)
    • Burden alleviation support
     

    Hematology
    programs

    Gazyva®

    NSSF (In-hospital)

    • Co-payment (5%)
    • Burden alleviation Support

     

     

    CNS
    programs

    Ocrevus®

    NSSF (In-hospital)

    COOP (In-hospital)

    • Co-payment (5%)
    • Burden alleviation Support
    • Co-payment (10%)
     
    RA
    programs

    Actemra® SC

    NSSF (Retail Pharmacy)

    • Co-payment (10%)
     

    Foundation
    Medicine
    Testing

    FoundationOne®CDx

    FoundationOne®Heme

    FoundationOne®LiquidCDx

    All reimbursement bodies

    • Logistical Support

     



    Number of Patients enrolled in Roche Programs since 2016

    More Than Numbers.

     
     

    Oncology and 

    Hematology

    Central Nervous 

    System

    Rheumatoid 

    Arthritis

    Foundation

    Medicine Testing

    138
    patients
    50
    patients
    57
    patients
    103
    patients

     

     

     

     

    Eligible patients

    Understanding the Difference Can Make a Difference.

     

     

     

    Eligibility*:

    Patients covered by NSSF who are prescribed a Roche product by their treating physicians as per local label and NSSF approval.

     

    * For Ocrevus - NSSF + COOP
    * For FMI testing - All reimbursement bodies

     

     

     

    Required documents

    Understanding the Difference Can Make a Difference.

     
     

    Doctor

    Documents needed

     

    • Signed Informed Consent Form
    • Doctor Prescription (by treating physician and patient/caregiver)

     

     

     

    Patient

    Documents needed

     

    • Doctor Prescription
    • National ID
    • The consent form signed by treating physician& patient
    • NSSF Number 
    • NSSF pre-approval (for in-hospital treatments) *

    * If applicable

     

     

     

     

    For Ocrevus

     
     
     
     
     

     

     

      

     

    For Tecentriq

     
     
     
     
     

     

     

     

     

    For Perjeta,

    Kadcyla, Alecensa

     

     
     

     

     

     

     

    For FMI Testing




     

     

     

     

     

    What will the patient go through?

    The journey.





     

    Step 1

     

    Step 2

     

    Step 3

     

    Step 4

     

    Step 5

     

    Treating physician informs patient about the program details, hand him/her the signed consent form, and shares the number of the program support center.

     

     

    Patient will contact the support center to understand the program requirements and needed documents.

     

    Support center will assess patient's eligibility for the program. If eligible the center will contact the patient and follow up on enrollment steps.

     

    After successful enrollment to the program, the support center will provide different types of support.

     

    Support center will keep following up with the enrolled patient(s) on his/her treatment until treatment discontinuation.


     

    How can we support you?

    We are here to help

     

    Roche representative

     

     

     

     

    Ziad Akiki

    Ziad Akiki

    Ziad.akiki@roche.com
    Roche Lebanon
     

    00961 3 755868

     

    Send an email to Ziad Akiki

    Support Center Representatives

    For Ocrevus

     

     

     

    PH-360-logo

    PH360

    rania@eph360.com
    www.eph360.com
     

    00961 3 801509

     

    Send an email to PH360

    Support Center Representatives

    For Tecentriq,

    Herceptin

    and Actemra

     

    ClinServ

    ClinServ

    hsadesk@cruisemea.com
     


    00961 8 1767374

     

    Send an email to ClinServ

    Support Center Representatives

    For Perjeta,

    Kadcyla, Gazyva,

    Alecensa, Hemlibra

     

    IQWIA

    IQVIA

    rochecareslebanon@iqvia.com

     

    00961 8 1022556

     

    Send an email to IQVIA

    Frequently asked questions

    Questions & Answers

     

    • My patient is already on the treatment, can I still enroll him in the product program?

      If the patient meets program’s eligibility criteria, whether newly or previously on the treatment, patient can always benefit from Co-payment Support.

      As for the Payment Facilitation Support services, they are applicable at treatment initiation exclusively.

    • Why do I need to sign the informed consent form?

      Physician’s signature is required since the informed consent form includes patient treatment plan; by signing the consent form the physician confirms patient’s medical eligibility. Besides medical eligibility, Rochecares ensures by consent signature physician approval on patient’s enrollment in the program.

    • Besides Medical Eligibility, how is eligibility determined?

      This program has been designed to support patients covered by the National Social Security Fund (NSSF) in Lebanon and who need support affording the cost for their Roche prescribed treatment. Patients eligible for support are patients with a valid medical prescription from a treating physician and enrolled in the NSSF.

      As for patients prescribed “Foundation Medicine” test, Roche Cares PSP will provide them with the logistical support needed.

    • What is my role in the program?

      After you have independently diagnosed and prescribed your patient a treatment/ test plan which involves taking a Roche Lebanon SARL product/ service, you are kindly asked to:

       

      • Inform the patient about the availability of RocheCares financial assistance/logistical support program
      • Complete with the patient the informed consent form
      • Submit the consent form to IQVIA and/or refer the patient to RocheCares team by providing the patient with Roche cares contact details.
    • How long will my patients benefit from Rochecares program?

      Once patient’s eligibility is determined, they will benefit from the support throughout the treatment and enrollment period. Patients may withdraw the enrollment at any time.

      Roche Lebanon S.A.R.L and/ or IQVIA may, without liability and at its sole discretion, decide to stop patient’s participation in the program or terminate the program at any time and you as well as your patients will be notified accordingly.

    • How my patient information is kept confidential?

      Roche and IQVIA regard your privacy, as well as that of your patient, with the utmost respect and confidentiality. In order to ensure optimal support, documents, and information shall be collected by IQVIA. Data collected will be managed in accordance to applicable law under the laws of Lebanon and for the purposes specified in the signed Informed Consent Form.

    • Where is my data stored?

      The Data will be stored on IQVIAs database hosted and processed by IQVIA.

    • Is NSSF pre-approval needed for patient program enrollment?

      NSSF pre-approval is required for the enrollment of patients prescribed with in-hospital treatments.

     

    Stay connected

     
     



    In case of any adverse event occurring with any Roche Product, please report to Roche Local Safety Line +961 76 700 322 , or forward details to: beirut.safety_reporting.bs1@roche.com.

    Date: November 2021. M-LB-00000476

    Share
    Close

    • © 2025 Roche Levant
    • 23.05.2024
    • Cookie settings